Health ASCO 2023: IDH mutation and improved cognitive functions in brain tumor patients by Alexandra Hartman Editor-in-Chief June 4, 2023 written by Alexandra Hartman Editor-in-Chief June 4, 2023 38 2023-06-04 12:19:42 – ASCO 2023 ASCO 2023 Patients with this tumor with the IDH 1 and 2 mutation improve their motor and cognitive functions, in addition to avoiding long-term relapses. Grade 2 gliomas with a mutation in the IDH gene are malignant brain tumors that cause considerable morbidity and premature death. 1685882522 #Vorasidenib #stops #grade #glioma #surgery #delays #chemo #radium Share this: Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Related 0 comments 0 FacebookTwitterPinterestEmail Alexandra Hartman Editor-in-Chief Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity. previous post Despite Dementia, Bruce Willis Enjoys a Day at Disneyland with Wife and Children next post Amazon is negotiating with US carriers to provide low-cost mobile phone service You may also like Nuts & Heart Health: 30% Lower Attack Risk! December 13, 2025 HIPAA Privacy vs. Caregiver Access: A Growing Conflict December 13, 2025 Cohesin & DNA Repair: Two Forms, One Vital... December 8, 2025 Anosmia: The Early, Silent Indicator of Parkinson’s and... December 8, 2025 Congo Faces Its Deadliest Cholera Outbreak in 25... December 8, 2025 Over 50% of Injured Israeli Soldiers Battle PTSD December 8, 2025 Unveiling Type 2 Diabetes Subtypes: Understanding SIRD, SIDD, and... December 8, 2025 Rabies from Kidney Transplant: US Man’s Death December 8, 2025 Daratumumab & ASCT: Deeper, Longer Remission – Guidance December 8, 2025 Cold, Super Flu, or Covid: How to Spot... December 8, 2025 Leave a Comment Cancel Reply Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.
